本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viridian Therapeutics, Inc.

22.44
+0.61002.79%
成交量:167.19萬
成交額:3,684.20萬
市值:25.42億
市盈率:-6.49
高:22.46
開:21.89
低:21.68
收:21.83
52周最高:34.29
52周最低:13.18
股本:1.13億
流通股本:1.01億
量比:1.32
換手率:1.66%
股息:- -
股息率:- -
每股收益(TTM):-3.4579
每股收益(LYR):-3.3245
淨資產收益率:-65.74%
總資產收益率:-30.16%
市淨率:4.51
市盈率(LYR):-6.75

資料載入中...

2026/08/20

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/06/27

重要事件披露

Form 8-K - Current report
2026/06/26

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/08

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/07

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/05

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses